ロード中...
Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Oncolytic virotherapy with mutants derived from Herpes simplex virus (HSV) type 1 exhibit significant antitumor effects in preclinical models. Several mutants have now been tested in clinical trials for a variety of cancer types, and all have been found to be safe. While there have been hints of ant...
保存先:
| 出版年: | Curr Pharm Biotechnol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4233127/ https://ncbi.nlm.nih.gov/pubmed/21740359 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|